Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Papers: 12 Jun 2015 - 19 Jun 2015
Papers: 26 Jul 2013 - 2 Aug 2013
Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients.
Spinal Vision
Papers: 26 Sep 2015 - 3 Oct 2015
Papers: 28 Feb 2016 - 6 Mar 2016
Evidence Live Global Forum
A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.
Vitamin D and autoimmunity.
Papers: 15 Jan 2016 - 22 Jan 2016
Papers: 13 Sep 2013 - 20 Sep 2013
Systematic Review of the Economics of Multiple Sclerosis in Latin America.
Papers: 16 Oct 2015 - 23 Oct 2015
The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands.
Papers: 5 Jun 2015 - 12 Jun 2015
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
Why TH17 Cells Turn to the Dark Side
Papers: 27 Dec 2015 - 3 Jan 2016
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
PUMA Protein May Underlie Oligodendroglial Cell Death in MS
MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
Ultrahigh-Field MRI May Detect Additional Pathology in EAE
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »
